Internal Medicine, Medical Oncology · New York, NY
NPI
1578876876
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10065
Phone (212) 639-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
226 services
Medicare patients, 2024
91
Average age 72
Drug cost, 2024
$2.2M
355 prescriptions
Company payments, 2025
$1,081
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander Edward D Drilon was code 99215 (office e&m - established), 104 times for 53 patients. In total Alexander Edward D Drilon billed 226 services in 9 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 104 | 53 | $122.93 | $13K |
| 99214 Office E&M - Established | Office | 83 | 46 | $82.32 | $6,832 |
| 99205 Office E&M - New | Office | 18 | 18 | $163.03 | $2,934 |
By year: 2022 $49K for 461 services; 2023 $26K for 247 services; 2024 $24K for 226 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Edward D Drilon prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 34 prescriptions and refills. In total Alexander Edward D Drilon wrote 355 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 34 | 38 | Under 11 | $618K |
| Alecensa Alectinib Hcl | 30 | 31 | Under 11 | $359K |
| Ondansetron Hcl Generic | 26 | 34 | Under 11 | $189 |
| Xalkori Crizotinib | 24 | 24 | Under 11 | $580K |
| Pregabalin Generic | 23 | 23 | Under 11 | $288 |
| Retevmo Selpercatinib | 21 | 21 | Under 11 | $355K |
| Losartan Potassium Generic | 13 | 15 | Under 11 | $13.79 |
| Lorazepam Generic | 13 | 13 | Under 11 | $37.58 |
| Dexamethasone Generic | 12 | 12 | Under 11 | $112 |
Brand drugs: 132 claims; generic drugs: 223 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander Edward D Drilon $1,081 ($350 in general payments such as food, travel and fees and $731 for research) from 4 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $731.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.